A detailed history of Flc Capital Advisors transactions in Medtronic PLC stock. As of the latest transaction made, Flc Capital Advisors holds 4,109 shares of MDT stock, worth $335,294. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,109
Previous 4,234 2.95%
Holding current value
$335,294
Previous $333,000 10.81%
% of portfolio
0.09%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$76.84 - $91.03 $9,605 - $11,378
-125 Reduced 2.95%
4,109 $369,000
Q2 2024

Jul 15, 2024

BUY
$78.71 - $87.02 $28,729 - $31,762
365 Added 9.43%
4,234 $333,000
Q4 2023

Jan 18, 2024

BUY
$69.43 - $83.43 $105,603 - $126,897
1,521 Added 64.78%
3,869 $318,000
Q2 2023

Aug 11, 2023

BUY
$79.47 - $91.38 $186,595 - $214,560
2,348 New
2,348 $206,000
Q3 2022

Oct 14, 2022

BUY
$80.75 - $95.31 $285,128 - $336,539
3,531 New
3,531 $285,000
Q2 2022

Jul 27, 2022

SELL
$87.4 - $113.09 $173,052 - $223,918
-1,980 Closed
0 $0
Q1 2022

Apr 25, 2022

BUY
$100.58 - $112.38 $199,148 - $222,512
1,980 New
1,980 $220,000
Q4 2021

Jan 26, 2022

SELL
$99.53 - $127.75 $215,980 - $277,217
-2,170 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$118.19 - $131.5 $5,909 - $6,575
50 Added 2.36%
2,170 $269,000
Q4 2020

Feb 10, 2021

SELL
$100.57 - $117.14 $17,599 - $20,499
-175 Reduced 7.63%
2,120 $248,000
Q2 2020

Jul 10, 2020

SELL
$84.11 - $103.33 $85,371 - $104,879
-1,015 Reduced 30.66%
2,295 $214,000
Q1 2020

Apr 09, 2020

BUY
$72.92 - $121.3 $29,095 - $48,398
399 Added 13.71%
3,310 $285,000
Q2 2019

Aug 05, 2019

BUY
$84.15 - $99.38 $50,574 - $59,727
601 Added 26.02%
2,911 $285,000
Q1 2019

May 13, 2019

BUY
$82.45 - $93.79 $190,459 - $216,654
2,310 New
2,310 $210,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Flc Capital Advisors Portfolio

Follow Flc Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Flc Capital Advisors with notifications on news.